Interesting Modality: HCQ w/Others
The Market Ticker - Commentary on The Capital Markets
Logging in or registering will improve your experience here
Main Navigation
Full-Text Search & Archives

Legal Disclaimer

The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions.


The author may have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.

Market charts, when present, used with permission of TD Ameritrade/ThinkOrSwim Inc. Neither TD Ameritrade or ThinkOrSwim have reviewed, approved or disapproved any content herein.

The Market Ticker content may be sent unmodified to lawmakers via print or electronic means or excerpted online for non-commercial purposes provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media, to republish full articles, or for any commercial use (which includes any site where advertising is displayed.)

Submissions or tips on matters of economic or political interest may be sent "over the transom" to The Editor at any time. To be considered for publication your submission must include full and correct contact information and be related to an economic or political matter of the day. All submissions become the property of The Market Ticker.

Considering sending spam? Read this first.

2020-04-07 07:00 by Karl Denninger
in Editorial , 162 references Ignore this thread
Interesting Modality: HCQ w/Others*
[Comments enabled]

This is quite interesting....

The FDA has warnings that azithromycin “can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm.”

So instead, Alam replaced azithromycin with another decades-old antibiotic that doesn’t pose any known risks to the heart.

“Doxycycline is an anti-inflammatory with properties similar to azithromycin but without the safety concerns and without cardiac toxicity,” he said.

Now that's an interesting twist -- and it appears to be working.

This doctor reports 38 of the 47 patients he had, all of whom were very high risk, have stabilized with this regime.  It didn't work for everyone but the fact remains that this looks very promising for people who would otherwise likely be hosed straight-up; these are persons who would be rather likely to be killed by a simple flu.

Is this statistically significant?  Not standing alone -- but another word for "anecdote" is "clinical evidence", and when you have a group of people who are otherwise screwed and you can only improve the situation for someone who is likely to die then it certainly looks to me like a positive outcome -- especially when we're talking about people who can't use ZPAK due to their underlying health conditions.

Interestingly enough doxycycline is also an anti-malarial.....

The article in question mentions that the Henry Ford health system -- a very large hospital network in SE Michigan -- is using this combination as well and as a result we'll probably get some pretty good data soon.

Again, do not attempt to play doctor with this on your own -- this is a tetracycline antibiotic and some people are allergic to those medications, and it can cause tooth discoloration (permanent) in un-erupted teeth.  This would be a problem in both children and pregnant women for obvious reasons.  Additionally it can be very dangerous in people using warfarin and similar medications.

Go to responses (registration required to post)

User: Not logged on
Login Register Top Blog Top Blog Topics FAQ
User Info Interesting Modality: HCQ w/Others in forum [Market-Ticker] *
Login Register Top Blog Top Blog Topics FAQ